Warren is the former senior science editor of TheBody and TheBodyPro. He worked for the sites from 2008 (as an editorial intern) to 2017.
He has been awarded journalist fellowships from the HIV Research for Prevention conference, and the Logan Science Journalism program.
He is a member of the Association of Health Care Journalists, the National Association of Science Writers, Science Writers in New York, and Asian American Journalists Association.
Warren is a native New Yorker, born in Manhattan and raised in Queens.
Latest by Warren Tong
Over the past few years, a tiny – but slowly growing – number of people appeared to have had active, living, reproducing HIV completely eliminated from their bodies.
This Week in HIV Research: Increased Muscle Area After Starting Treatment Likely Due to Fat Accumulation
This week, a study finds that increased muscle area after starting HIV treatment may be due to fat accumulation within the muscle rather than new muscle formation.
This week, a study finds that abstinence-only programs continue to be ineffective at keeping young people from having sex, and censor valuable information on HIV prevention.
This week, a study finds that the average time it takes to for newly diagnosed patients to enter care is three months.
This week, a study review finds that early interventions in monkeys, such as broadly neutralizing antibodies, can help lead to viral suppression without treatment.
This week, a study finds that injectable cabotegravir, an investigational integrase inhibitor, is well tolerated and shows promise as pre-exposure prophylaxis (PrEP).
This Week in HIV Research: Effect of Viral Load Perception on Sex, and HIV Prevention Options Needed in U.S. Prisons
This week, a study finds that viral load perception may change sexual behaviors among HIV-positive men who have sex with men.
This week, a study finds a new key step in how HIV binds to CD4 cells, which could lead to the development of new HIV drugs.
PrEP (pre-exposure prophylaxis) is highly effective at preventing HIV, but uptake has been slow around the world. We asked providers and community leaders what they thought needed to happen for PrEP to reach everybody who needs it.
This Week in HIV Research: Early Treatment With Broadly Neutralizing Antibodies Suppresses SHIV in Monkeys
This week, a study finds that administering two broadly neutralizing antibodies very early on during infection helped monkeys achieve long-term viral suppression of simian HIV (SHIV).